What is Big Think?  

We are Big Idea Hunters…

We live in a time of information abundance, which far too many of us see as information overload. With the sum total of human knowledge, past and present, at our fingertips, we’re faced with a crisis of attention: which ideas should we engage with, and why? Big Think is an evolving roadmap to the best thinking on the planet — the ideas that can help you think flexibly and act decisively in a multivariate world.

A word about Big Ideas and Themes — The architecture of Big Think

Big ideas are lenses for envisioning the future. Every article and video on bigthink.com and on our learning platforms is based on an emerging “big idea” that is significant, widely relevant, and actionable. We’re sifting the noise for the questions and insights that have the power to change all of our lives, for decades to come. For example, reverse-engineering is a big idea in that the concept is increasingly useful across multiple disciplines, from education to nanotechnology.

Themes are the seven broad umbrellas under which we organize the hundreds of big ideas that populate Big Think. They include New World Order, Earth and Beyond, 21st Century Living, Going Mental, Extreme Biology, Power and Influence, and Inventing the Future.

Big Think Features:

12,000+ Expert Videos


Browse videos featuring experts across a wide range of disciplines, from personal health to business leadership to neuroscience.

Watch videos

World Renowned Bloggers


Big Think’s contributors offer expert analysis of the big ideas behind the news.

Go to blogs

Big Think Edge


Big Think’s Edge learning platform for career mentorship and professional development provides engaging and actionable courses delivered by the people who are shaping our future.

Find out more

Gene Therapy Closes in on AIDs Cure

February 12, 2009, 12:39 PM

Amidst all the economic tumult, a medical revolution is quietly unfolding, moving us a step closer to the age of genetic therapies, a step beyond the era of pharmacology and ever closer to cures for scourges like HIV/AIDs.  A new study published today in the New England Journal of Medicine offers compelling new evidence that future gene therapies may offer a cure for HIV.

The study follows a two-year remission of an HIV infected man after having been given a bone marrow transplant to treat an onset of leukaemia.  This case represents the first strategic use of therapy to achieve sustained HIV remission.  While an accompanying editorial in NEJM stresses this breakthrough does not represent a cure in and of itself, it does herald the promise of one based on gene mutations (CCR5) that have been proven to confer protection against HIV. 

What remains to be seen is how quickly these medical possibilities can be translated into therapeutic realities, and that, of course, brings us right back to the economic tumult.


Gene Therapy Closes in on A...

Newsletter: Share: